General Manager of International
Joined Exact Sciences: 2019
Key Responsibility: Oversees international efforts for the company.
Previous Employment: Torsten Hoof joined Genomic Health in 2017 as Senior Vice President, International. Torsten was also the Vice President and Head of Oncology EMEA at Baxalta, where he built the company’s oncology presence in Europe. Torsten was also the European General Manager for Endocyte, where he established its European organization designed to bring an innovative, precision medicine solution to patients with ovarian cancer. During his 10 years at Bristol-Myers Squibb, he led the global haemato-oncology franchise and was EMEA General Manager and Vice President for HIV and Primary Care. In his career with Roche, Torsten led the Tamiflu launch as a Global Business Leader and established Roche’s German leadership position in Virology. Torsten also served as an Independent Director at HRA Pharma until its acquisition by Goldman-Sachs/Astorg in 2016.
Education: PhD, Masters (Distinction), University of Hannover, Germany. Alumnus of the Boehringer Ingelheim Fonds, Germany.